Dolon Ltd Competitors

Navigating Market Access with Trusted Insights and Valid Perspectives At Valid Insight, we provide trusted insights, valid perspectives, and specialized expertise to assist our clients in navigating complex market access challenges. We understand the intricacies of market access across pharmaceuticals, diagnostics, and medical devices. Our expertise spans the entire product lifecycle, ensuring clients have the right strategies to optimize access, communicate value, and succeed in payer negotiations. For nearly a decade, we have supported companies in overcoming some of the most complex market access hurdles, delivering pragmatic, results-driven solutions that create lasting impact. Why Work with Us? ◆ A legacy of trust, credibility, and proven results, backed by extensive industry experience. ◆ A diverse, highly skilled team based across Europe, ensuring both global perspective and local expertise. ◆ Seamless integration with the Bioscript Group, providing access to medical and regulatory communications specialists. ◆ Market access expertise that helps clients confidently navigate payer landscapes, pricing and reimbursement strategies, and negotiation processes. 📍 UK Office Address: Greenway House, Larkwood Way, Tytherington Business Park, Macclesfield, Cheshire, SK10 2XR 📩 Contact us: discover@bioscriptgroup.com 📞 +44 (0) 20 3750 9833 🌐 Visit our website

At Mtech Access––Powered by Petauri™, we partner with Pharma and Medtech leaders to drive optimal global commercialisation. Programmes of support include: • Evidence, pricing and access strategy • Development of a robust evidence base • National, regional and local reimbursement, and formulary inclusion • Communication of value to clinical and financial decision-makers Our clients benefit from collaborative, expert-driven, solutions-focused partnerships. We challenge and inspire them to achieve the best results, applying innovation and agility to everything we do. Our centres of excellence: • Strategic consulting • Expert opinion and insights • Evidence synthesis • Economic modelling, data analysis, and statistics • Value propositions, storytelling, and positioning • Cutting-edge digital and design We have extensive experience in all therapy areas and deep expertise in rare disease, oncology, respiratory, diabetes and obesity, neurology, and immunology. Why follow us on LinkedIn: With insights from our in-house market access and HEOR specialists, as well as an external network of healthcare professionals and other stakeholders, follow our LinkedIn page for: - Discussion of recent and ongoing global market access trends - Upcoming webinars and events, including interviews with healthcare professionals and other experts - Policy updates and insights relevant to local healthcare markets - Explanation and discussion of health economics and evidence generation techniques - Showcase of our latest value communication and digital tools - Interviews with Mtech Access colleagues, insights into our culture and opportunities to join our team

Putnam, an Inizio Advisory Company, is a premier strategic consulting partner for pharmaceutical and life science companies serving a range of biopharmaceutical, diagnostics, medtech, and private equity/venture capital clients. For more than 30 years, we have provided high-impact strategic advice and analytical services, helping our clients solve their most complex challenges across the patient journey and franchise lifecycle to bring preventions and treatments to those that need them. We offer an unparalleled depth and breadth of advisory service expertise combined with scientific and technical capabilities across strategic and therapeutic areas. We listen to client needs, help shape hypotheses, analyze data, and advise on the strategy of life-changing therapies, empowering better decisions to create long-term value for patients. Our Putnam PHMR team is part of our Value, Pricing and Access (VPA) practice area function, where our team members bring a breadth of knowledge across scientific and technical capabilities. We are a team of highly qualified HTA experts, health economists, and research scientists, helping clients to demonstrate and communicate value essential for pricing and market access success. We are proudly part of Inizio Advisory, a trusted advisor for pharmaceutical and life science companies offering sector specific connected solutions.